Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D10AD01	KETREL	G	Tretinoin - 0.05%	0.05%	Cream	397,777 L.L
G04BE08	TYRA	G	Tadalafil - 20mg	20mg	Tablet, film coated	1,369,376 L.L
J01MA02	CIPROMID	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film coated	331,929 L.L
L01EB02	TARESSA 100	G	Erlotinib (HCl) - 100mg	100mg	Tablet, film coated	82,247,256 L.L
L02BG03	ZORTEX	G	Anastrozole - 1mg	1mg	Tablet, film coated	1,944,092 L.L
M01AB05	DILO	G	Diclofenac potassium - 50mg	50mg	Tablet	223,974 L.L
N01AX10	DORMIFOR	G	Propofol - 1%	1%	Injectable emulsion	1,081,473 L.L
N03AX09	LEPIGINE	G	Lamotrigine - 100mg	100mg	Tablet, scored	1,163,768 L.L
P01AB01	METROLAG	G	Metronidazole - 250mg	250mg	Tablet	130,353 L.L
R05X	COFEX	G	Paracetamol - 33.3mg/5ml, Guaifenesin - 33.3mg/5ml, Oxomemazine HCl - 1.65mg/5ml		Syrup	154,542 L.L
V03AB35	PLIBADEX	G	Sugammadex - 200mg/2ml	200mg/2ml	Injectable solution	47,914,365 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,252,461 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
C03DA05	KERENDIA	G	Finerenone - 20mg	20mg	Tablet, film coated	6,353,687 L.L
C09CA04	IRBESARTAN ARROW	G	Irbesartan - 150mg	150mg	Tablet	1,326,373 L.L
D10AD01	RETACNYL - 0.05 %	G	Tretinoin - 0.05%		Cream	584,571 L.L
J01CR05	PIPERACILINA/TAZOBACTAM SALA	G	Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g		Injectable powder for solution	913,813 L.L
J01MA02	CIPROPHARM	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film-scored	354,774 L.L
J07AH	MENFIVE	G	Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine -		Injectable freeze dried powder + diluent	3,527,587 L.L
L01EB02	APO-ERLOTINIB	G	Erlotinib (HCl) - 150mg	150mg	Tablet	91,523,229 L.L
M01AB05	JOFLAM	G	Diclofenac potassium - 50mg	50mg	Tablet, film coated	322,522 L.L
N01AX10	PROPOFOL 1% MCT/LCT FRESENIUS	G	Propofol - 1%	1%	Injectable emulsion	847,965 L.L
N05BA08	ANXYL	G	Bromazepam - 3mg	3mg	Tablet, scored	167,660 L.L
P01AB01	METRONIDAZOLE	G	Metronidazole - 250mg	250mg	Tablet	6,540,034 L.L
V03AB35	RELANCIUM	G	Sugammadex - 100mg/ml	100mg/ml	Injectable solution	45,660,028 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	568,445 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
C09CA04	ZIOREL	G	Irbesartan - 150mg	150mg	Tablet, film coated	575,933 L.L
C10AA07	APO-ROSUVASTATIN	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet	599,354 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.05%	0.05%	Solution	623,287 L.L